Towards Personalized Medicine in Breast Cancer
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".
Deadline for manuscript submissions: closed (31 October 2025) | Viewed by 433
Special Issue Editor
Special Issue Information
Dear Colleagues,
Breast cancer is one of the most prevalent cancers among women and is recognized as a highly heterogeneous disease. Despite significant progress in early detection and treatment, challenges such as recurrence, metastasis, and drug resistance remain major obstacles. Advances in genomics, molecular biology, and bioinformatics have revolutionized the field, enabling personalized approaches to breast cancer management through tailored diagnostic tools and therapies.
This Special Issue of the Journal of Personalized Medicine invites high-quality contributions exploring personalized approaches across the spectrum of breast cancer care, including prevention, early detection, diagnosis, treatment, and survivorship. Topics of interest include innovative immunotherapies, targeted treatments, surgical advancements, resistance mechanisms, and translational research to improve patient outcomes. Studies addressing clinical, molecular, and bioinformatic perspectives are particularly welcome.
Dr. Eun Young Kim
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- personalized medicine
- breast cancer
- targeted therapy
- immunotherapy
- pharmacogenomics
- biomarkers
- treatment resistance
- early detection
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
